Legit Stem Cell Therapies Advance as Bogus Clinics Proliferate

June 12, 2018

(Medscape) – Stem cell transplantation research continues to show encouraging benefits in inducing long-term remission of multiple sclerosis (MS), but many are cashing in on the hopes raised by headlines of “game-changing” results, to the detriment of patients as well as the research field in general, experts say.

Recommended Reading